Evli Yrityslaina vs UBS Lux Equity Fund Biotech USD

Evli Yrityslaina vs UBS Lux Equity Fund Biotech USD

1. Evli Yrityslaina

  • Security

    Evli Corporate Bond B

  • Fee

    0.97%

  • ISIN

    FI0008801097

  • Holdings

    18

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 18 holdings in Evli Yrityslaina, where the largest holding is Societe Generale (1.9), followed by Eurogrid (1.52) and Redeia (1.28). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Evli Yrityslaina and UBS Lux Equity Fund Biotech USD.

Evli Yrityslaina UBS Lux Equity Fund Biotech USD
1. Societe Generale SA
France
1.9 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Eurogrid GmbH
Germany
1.52 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Redeia Corporacion SA
Spain
1.28 %
3. Moderna Inc
9.21 %
4. UBS Group AG
Switzerland
1.23 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Mölnlycke Holding AB
Sweden
1.19 %
5. AbbVie Inc
USA
5.53 %
6. Statnett SF
Norway
1.16 %
6. Gilead Sciences Inc
USA
4.66 %
7. Telenor ASA
Norway
1.14 %
7. Amgen Inc
4.3 %
8. Ellevio AB
Sweden
1.12 %
8. BioNTech SE
4.13 %
9. BNP Paribas SA
France
1.1 %
9. Karuna Therapeutics Inc
3.75 %
10. TenneT Holding BV
Netherlands
1.02 %
10. Royalty Pharma Plc
3.37 %
11. Siemens Financieringsmaatschappij NV
Netherlands
1.02 %
-
12. Loomis B
Sweden
1.01 %
-
13. SpareBank 1 Sør-Norge ASA
Norway
1 %
-
14. Akelius Residential Property Finance BV
1 %
-
15. Allianz SE
Germany
0.97 %
-
16. NTI Group Holding ApS
Denmark
0.92 %
-
17. Kojamo Oyj
Finland
0.89 %
-
18. Fortum Oyj
Finland
0.86 %
-

The list of fund holdings was last updated on June 5, 2025.